OR WAIT null SECS
May 07, 2019
The companies will work together to develop observational research analytics to assess treatment outcomes for areas of unmet need in oncology.
May 06, 2019
MilliporeSigma event scheduled to recognize biotech challenges and support development potential.
May 03, 2019
In collaboration with Pall Corportion, biotech company Freeline completed the first full-scale run at its newly commissioned, GMP gene-therapy manufacturing facility in the UK.
May 01, 2019
NHS England and three pharma companies have agreed to work together to find and cure tens of thousands more people with hepatitis C, potentially leading to Britain becoming the first country to eliminate the virus.
The companies will join forces to use artificial intelligence (AI) and machine learning to discover and develop new treatments for two chronic diseases.
Intertek has announced the expansion of its pharmaceutical services laboratory in Melbourn, near Cambridge, UK, through the acquisition of a new 20,000 sq. ft facility.
April 18, 2019
The company passed a seven-day FDA surveillance GMP inspection and announced two upcoming manufacturing partnerships.
April 17, 2019
EDCTP has granted EUR10 million to a collaboration of African and European antimalarial drug researchers to support late-stage clinical trials of a novel antimalarial combination.
Sandoz has signed an agreement with Shionogi for the commercialization rights of Rizmoic (naldemedine) within specific key European markets.
April 15, 2019
Catalent’s acquisition of Paragon Bioservices will provide expertise and in expanding gene and cell therapy markets.